Company / Shareholders' Equity
Mereo BioPharma Group plc Shareholders' Equity History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$40.9M
FY2025
5-year range
$40.9M / $61.0M
FY2023-FY2025
Trend
-32.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $51M to $41M over the past 2 years.
Based on SEC 10-K filings.
$41M in FY2025.
Declined from $51M to $41M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shareholders' equity decreased 32.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.87 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $40.9M | -32.9% |
| FY2024 | $61.0M | +20.6% |
| FY2023 | $50.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 27, 2026